EP3641775
COMBINATION OF A MCL-1 INHIBITOR AND A STANDARD OF CARE TREATMENT FOR HEMATOLOGIC CANCERS, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
:
EP einkaleyfi: Þýðing ekki lögð inn:
21.6.2018:
6.12.2023:
18731845.6
:
20.6.2038
:
COMBINATION OF A MCL-1 INHIBITOR AND A STANDARD OF CARE TREATMENT FOR HEMATOLOGIC CANCERS, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
21.6.2018
6.12.2023
:
Les Laboratoires Servier:
35, rue de Verdun, 92284 Suresnes Cedex, FR
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
WEI, Andrew:
Surrey Hills Victoria 3127, AU
:
MOUJALLED, Donia:
Lalor Victoria 3075, AU
:
POMILIO, Giovanna:
Pascoe Vale Victoria 3044, AU
:
GENESTE, Olivier:
92500 Rueil-Malmaison, FR
:
MARAGNO, Ana-Leticia:
78290 Croissy-Sur-Seine, FR
:
201762523389 P:
22.6.2017:
US
:
17189550:
6.9.2017:
EP
:
EP2018066551:
21.6.2018
:
A61K 31/519, A61K 31/5377, A61K 31/55, A61P 35/00, A61K 45/06